Atualização do protocolo de insuficiência cardíaca: sessão crônica

Abstract

Chronic heart failure (CHF) remains one of the most complex and high-impact clinical conditions in contemporary practice, not only due to its elevated morbidity and mortality rates but also because of the substantial number of preventable readmissions and the resulting burden on healthcare systems. The care trajectory of these patients is commonly characterized by discontinuity, gaps in care, and heterogeneity in therapeutic approaches. These issues become even more pronounced during the transition from hospital discharge to outpatient follow-up, a period marked by heightened clinical vulnerability and increased susceptibility to organizational shortcomings within the care continuum. In this context, the development of clinical flowcharts emerges as a strategic instrument to guide decision-making, mitigate care deficiencies, and standardize therapeutic pathways. Such tools enable the translation of complex recommendations into clear, structured, and practical actions applicable to routine clinical practice. By synthesizing key steps, therapeutic priorities, and critical monitoring points, these instruments foster greater accuracy in diagnostic evaluation and therapeutic optimization. This review was undertaken with the objective of designing flowcharts specifically aimed at the management of chronic heart failure. To achieve this, an extensive analysis of major international and national guidelines, relevant clinical trials, and multicenter registries published between 2014 and 2024 was conducted. The synthesis process incorporated updated diagnostic criteria, evidence-based therapeutic recommendations, and follow-up strategies that have demonstrated consistent benefits in patient outcomes. The delineation of clear stages for clinical reassessment—including timely initiation and titration of medications, evaluation for advanced therapies, biomarker monitoring, and verification of treatment adherence—supports early identification of clinical instability and reduces the likelihood of decompensations leading to readmissions and adverse outcomes. Thus, the proposed flowcharts are presented as robust clinical tools capable of integrating scientific knowledge, clinical practice, and standardized care pathways in an operational and accessible format. Their implementation has the potential to harmonize clinical conduct, enhance patient safety, and improve the quality of care delivered to individuals with chronic heart failure, contributing to more stable longitudinal management aligned with international best practices.